Zydus Lifesciences Secures U.S. Rights for BEIZRAY in Partnership with Zhuhai Beihai Biotech
In a strategic move to enhance cancer treatment options in the United States, Zydus Lifesciences has entered into an exclusive licensing, supply, and commercialization agreement with Zhuhai Beihai Biotech Co. This partnership focuses on the U.S. commercialization of BEIZRAY (Albumin Solubilized Docetaxel Injection), a novel formulation designed to improve therapeutic outcomes for cancer patients. Zydus […]







